West Australian biotech, Lixa, has completed its first clinical human trial, which has confirmed the safety and tolerability of inhaled NeoX-101. …
Clinical trial success kicks off $5m fund-raising round for WA’s Lixa
June 5, 2025 Australian Biotech
Latest Video
New Stories
-
Hospital pharmacists use Rare Cancers Awareness Day to call for reform
June 27, 2025 - - Latest News -
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 - - Latest News -
Mark Butler retains position on critical Cabinet committee
June 26, 2025 - - Latest News -
New Zealand to streamline access to ADHD treatments
June 26, 2025 - - Latest News -
CLEO strengthens FDA submission following Access to globally recognised Biobank
June 25, 2025 - - Australian Biotech -
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - - Latest News -
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 - - Latest News